- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03252470
The BlackBox Study
A Prospective, Post Market, Feasibility Study to Assess the Practical Utility of the OR BlackBox Platform When Used to Compare Surgical Technique During 2D Versus 3D Laparoscopic Bariatric Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Data published in 2008 estimated the global number of surgical procedures performed annually as 234 million with a rate of major perioperative complications reported between 3% and 17% in industrialized countries. As a derivative of these figures, it is estimated that approximately 7 to 40 million major complications occur worldwide each year. Studies have shown that between 39.6% and 54.2% of surgical complications occur in the operating room (OR); furthermore, it has been suggested that one third to half of all surgical errors are potentially avoidable. These findings have brought considerable attention to quality improvement in the technically demanding field of laparoscopic surgery wherein the risk of intraoperative error is increased by the sociotechnical complexity of the operative environment. In particular, there has been growing interest in evaluating surgical processes from a human factors point of view, as human factors, such as fatigue and mental workload, have become increasingly recognized as root causes of adverse surgical events and outcomes.
Among the most commonly reported errors in conventional laparoscopic surgery are technical errors associated with impaired depth perception; laparoscopic surgeons rely on two-dimensional (2D) video displays to guide their work in a three-dimensional (3D) space, resulting in the loss of depth perception and spatial orientation, as well as the experience of increased visual and cognitive load. Technical errors can be defined as manual errors of the surgeon (e.g. damage to adjacent structures) and procedural errors due to a lack of surgeon proficiency or experience. These errors are frequently described, especially when evaluating closed malpractice cases. These factors have been extensively examined but still remain controversial. A major limitation of error analyses of closed malpractice cases and root cause analyses of complications is the hindsight bias introduced through the knowledge of patient outcome.
Laparoscopic cameras with 3D display functionality were first developed in the early 1990s. The poor image quality produced by early cameras resulted in pronounced physical side effects, including dizziness, headache, and nausea; however, a significant technological advancement in the field of 3D laparoscopy has dramatically improved the usability of these systems. Despite these improvements and the potential for improved surgical safety, the use of 3D laparoscopic equipment remains limited in modern surgical centers. Outdated and conflicting research findings regarding the effectiveness of these systems and the physical side effects associated with their use may be contributing to slow adoption into clinical practice. Furthermore, investigations assessing the impact of 3D laparoscopy on surgical performance in the clinical setting are notably lacking. Thus, robust comparative evaluations of modern 2D and 3D laparoscopic surgical display systems in clinical settings are required to clearly elucidate the impact of 3D laparoscopy on surgical performance and safety with an aim to establish best practices in laparoscopic surgery.
The restoration of stereoscopic vision in laparoscopic surgery has the potential to mitigate these challenges and, to this end, the introduction of 3D stereoscopic displays in laparoscopic surgery may be beneficial to improving surgical safety. The purpose of this study is to compare the impact of 2D versus 3D visualization on surgical performance, as measured by the OR BlackBox Platform, during laparoscopic Roux-en-Y gastric bypass surgery.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B
- St. Michael's Hospital, Division of Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- ≥ 18 years of age
- Scheduled to undergo elective, primary roux-en-y gastric bypass surgery
- BMI of 35 to 54.9
- Willing and able to provide informed consent
Exclusion Criteria:
- Previous open abdominal surgery
- Previous open or laparoscopic upper GI surgery
- Contraindicated for laparoscopic bariatric surgery
- Unable or unwilling to provide informed consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
2D laparoscopic surgeries
Two-Dimensional Laparascopic Surgical Video System
|
Laparoscopic Roux-en-y Gastric Bypass Surgery
|
|
3D laparoscopic surgeries
Three-Dimensional Laparascopic Surgical Video System
|
Laparoscopic Roux-en-y Gastric Bypass Surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantify operative performance and intraoperative errors
Time Frame: 12 months
|
This pilot study will quantify operative performance and intraoperative errors after the introduction of the 2D and 3D technology using the following tools:
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Significant adverse events
Time Frame: one month
|
1. Clinically significant adverse events related to the device(s) and/or procedure
|
one month
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2015-SE-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopic Roux-en-y Gastric Bypass
-
Medtronic - MITGCompleted
-
Jessa HospitalNot yet recruiting
-
Wageningen UniversityRijnstate HospitalUnknownRoux-en-Y Gastric BypassNetherlands
-
North Dakota State UniversityNeuropsychiatric Research Institute, Fargo, North DakotaCompletedRoux en Y Gastric BypassUnited States
-
Mayo ClinicCompletedRoux-en-Y Gastric Bypass | Gastric Bypass | Bariatric SurgeryUnited States
-
North Dakota State UniversityNational Institutes of Health (NIH)CompletedRoux en Y Gastric Bypass SurgeryUnited States
-
Rijnstate HospitalCompletedRoux-en-Y Gastric Bypass | Gastric Emptying | Bariatric SurgeryNetherlands
-
North Dakota State UniversityNeuropsychiatric Research Institute, Fargo, North DakotaCompletedSleeve Gastrectomy | Roux en Y Gastric BypassUnited States
-
CARLOS ZERRWECK LOPEZCompletedRoux-en-Y Gastric Bypass | Bariatric Surgery | Metabolic SurgeryMexico
-
Rijnstate HospitalCompleted
Clinical Trials on Laparoscopic Roux-en-y Gastric Bypass Surgery
-
Göteborg UniversitySuspendedQuality of Life | Obesity | Physical Activity | Bariatric Surgery | Post-operative ComplicationsSweden
-
Instituto Nacional de Ciencias Medicas y Nutricion...Completed
-
Kaunas University of MedicineUnknown
-
Puerta de Hierro University HospitalEnrolling by invitationPostoperative Complications | Weight Loss | Morbid ObesitySpain
-
CARLOS ZERRWECK LOPEZCompletedObesity | Bariatric Surgery Candidate | Type2 Diabetes | Laparoscopic Gastric BypassMexico
-
GEM Hospital & Research CenterRecruitingConventional Vs Tailored Limb Lengths in Laparoscopic Roux-en Y Gastric Bypass Surgery (TAILO-R-YGB)Obesity | Bariatric Surgery Candidate | Metabolic Disease | Metabolic Surgery | RYGBIndia
-
University of PatrasCompletedType 2 Diabetes | Morbid Obesity | Bariatric SurgeryGreece
-
ClinTrio Ltd.UnknownMorbid Obesity Requiring Bariatric SurgeryBelgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
-
Hospices Civils de LyonRecruiting
-
Asia Metabolic Surgery Research GroupE-DA HospitalUnknownType 2 Diabetes Mellitus - Poor ControlTaiwan